United States · FDA National Drug Code directory
lurasidone hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-639_6e4065a5-2672-4ef4-996d-f9d2f58970d3
- Product NDC
- 67877-639
- Form
- TABLET, FILM COATED
- Composition / generic term
- lurasidone hydrochloride
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230104
- Source listing expiry
- 20261231
Source-listed ingredients
- LURASIDONE HYDROCHLORIDE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (67877-639-05) · 67877-639-05
- 30 TABLET, FILM COATED in 1 BOTTLE (67877-639-30) · 67877-639-30
- 10 BLISTER PACK in 1 CARTON (67877-639-38) / 10 TABLET, FILM COATED in 1 BLISTER PACK (67877-639-33) · 67877-639-38
- 90 TABLET, FILM COATED in 1 BOTTLE (67877-639-90) · 67877-639-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →